Amicus Therapeutics (FOLD) Institutional Ownership

Of the 322 institutional investors that purchased Amicus Therapeutics' stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: HBK Investments L P ($15.25M), Vestal Point Capital LP ($11.90M), Pentwater Capital Management LP ($11.50M), Wellington Management Group LLP ($8.09M), Norges Bank ($7.48M), State Street Corp ($5.32M), and Assenagon Asset Management S.A. ($5.09M).

Institutional investors have bought a total of 156,388,495 shares in the last 24 months. This purchase volume represents approximately $1.86B in transactions.

Of the 101 institutional investors that sold Amicus Therapeutics' stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: Wellington Management Group LLP ($27.75M), Perceptive Advisors LLC ($14.05M), Redmile Group LLC ($8.34M), Pictet Asset Management Holding SA ($5.89M), William Blair Investment Management LLC ($5.26M), Massachusetts Financial Services Co. MA ($3.58M), and Avoro Capital Advisors LLC ($2.98M).

Institutional investors have sold a total of 107,642,833 shares in the last 24 months. This volume of shares sold represents approximately $1.15B in transactions.